The bioavailability of three altretamine formulations
- 1 December 1989
- journal article
- clinical trial
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 11 (6) , 218-223
- https://doi.org/10.1007/bf01959414
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Generalization of distribution – Free confidence intervals for bioavailability ratiosEuropean Journal of Clinical Pharmacology, 1985
- Studies of the mode of action of antitumour triazenes and triazines—V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolismBiochemical Pharmacology, 1984
- A new statistical procedure for testing equivalence in two-group comparative bioavailability trialsJournal of Pharmacokinetics and Biopharmaceutics, 1984
- Bayesian Approach to Bioequivalence Assessment: An ExampleJournal of Pharmaceutical Sciences, 1983
- Hexamethylmelamine as a single agent in the treatment of small-cell carcinoma of the lungAmerican Journal of Clinical Oncology, 1982
- Hexamethylmelamine and hexamethylmelamine hydrochlorideInternational Journal of Clinical Pharmacy, 1982
- Influence of ascites on the pharmacokinetics of hexamethylmelamine andN-demethylated metabolites in ovarian cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1981
- The role of hexamethylmelamine in advanced ovarian carcinoma treatmentGynecologic Oncology, 1981
- An aid to decision-making in bioequivalence assessmentJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Determination of hexamethylmelamine and metabolites in plasma or serum by gas—liquid chromatography with a nitrogen-sensitive detectorJournal of Chromatography B: Biomedical Sciences and Applications, 1980